跳至主要内容
临床试验/ACTRN12610000064000
ACTRN12610000064000招募中1 期

A prospective Randomised Controlled Trial assessing recombinant LH supplementation in patients with a relative reduction in Luteinising Hormone (LH) levels during In Vitro Fertilisation/Intracytoplasmic sperm Injection (IVF/ICSI) treatment.

IVFAustralia0 个研究点目标入组 697 人开始时间: 2010年1月20日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
697

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • 1) IVF/ICSI using long pituitary down regulation.
  • 2) No more than 3 stimulated IVF/ICSI treatment cycles before.
  • 3) Not reached 42nd birthday.
  • 4) Consent to undergo study.
  • 5) Regular menstrual cycle.

排除标准

  • 1) Oocyte donors.
  • 2) Failure to achieve down regulation within 6 weeks of starting gonadotrophin releasing hormone agonist (GnRH a), are to be excluded for the study.
  • 3) Patients who have already taken part in the study

研究者

发起方
IVFAustralia

相似试验